The purpose of this study is to demonstrate the feasibility, acceptability, and preliminary effectiveness of a focal mass drug administration program for household members of pregnant women to protect against malaria in pregnancy.
Primary residence (i.e., where a person lives for ≥ 6 months per year) in Kasese District with no plans to change residency in subsequent 6 months
Able and willing to comply with all study procedures and be available for the duration of the study
Able and willing to consent to study procedures as documented on informed consent form. For children (age <18 years), parent or guardian must provide consent. Children age ≥8 to 17 years will also be asked to provide written assent.
Temporary or part-time residence in Kasese District (i.e., where a person lives for < 6 months per year)
Known plans to move within the next 6 months
Unable or unwilling to provide consent
Anything that would place the individual at increased risk or preclude the individual's full compliance with or completion of the study
University of North Carolina, Chapel Hill
Lead sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborator